User data for 2022/23 (1st August 2022 – 31st July 2023)

1st July 2023

The use of the SCRIPT eLearning programme continues to grow across our portfolios, and our latest figures show a 24% increase in module completions compared to 1^st August 2021 to 31^st July 2022. SCRIPT aims to provide standardised education relating to prescribing and therapeutics. Thank you for continuing to support SCRIPT and engage with the programme.

Back

More News

New Modules Under Development

13th April 2026

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

25th February 2026

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....

New Module Launched – Pharmaceutical Management of Neonates: Use of the BABY FLAMINGo! Tool

5th February 2026

We are pleased to announce the launch of our new elearning module, Pharmaceutical Management of Neonates: Use of the BABY FLAMINGo! Tool. Designed for pharmacists caring for neonatal patients, this module provides core knowledge to support systematic...

New SCRIPT Research Associate

5th January 2026

We are delighted to welcome the newest member of the SCRIPT Team, Divya Singh who joins us as a Research Associate. Divya holds a BSc in Biochemistry and a Master of Public Health (MPH) from the University of Birmingham. Before joining SCRIPT, she spent a year at the...